Longeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones
– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty…
Year: 2023
Celularity’s Placental-Derived Allogeneic Cell Therapy Provides Clinically Meaningful Benefit and Durable Biological Effect in Patients with Moderate to Severe Crohn’s Disease in Phase 1, Phase 1b/2a and Phase 1b Studies
Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit…
Nexcella, Inc. Announces Additional Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in Relapsed/Refractory AL Amyloidosis Patients, Duration of Response Not Yet Reached
NXC-201 treatment continues to demonstrate 100% complete response rate in 6 relapsed/refractory AL amyloidosis patients…
Immix Biopharma Subsidiary Nexcella, Inc. Announces Additional Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in Relapsed/Refractory AL Amyloidosis Patients, Duration of Response Not Yet Reached
NXC-201 treatment continues to demonstrate 100% complete response rate in 6 relapsed/refractory AL amyloidosis patients…
Madrigal Announces Additional Positive Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH with Liver Fibrosis
As previously reported, resmetirom demonstrated improvements in NASH and liver fibrosis on liver biopsies, the…
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
– Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by…
Icosavax Provides Corporate Update and Anticipated Milestones for 2023
– Recently reported positive six-month immunogenicity data for IVX-121 against RSV; first clinical evidence of…
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
Anticipates commencing pivotal pharmacokinetic (PK) trial for AQST-109 (epinephrine sublingual film) in second half of…
Recludix Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in platform approaches…
Ocular Therapeutix™ Provides 2022 Year End Corporate Update and Reviews Expected 2023 Milestones
Dextenza® Net Product Revenue in the Fourth Quarter of 2022 is Estimated to be $13.6…
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT NEW YORK, Jan. 06,…
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Hamsters infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had…
Aclaris Therapeutics Provides 2023 Outlook
WAYNE, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Nabriva Therapeutics Provides Corporate Update
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To…
Mersana Therapeutics Provides Business Update and Announces Strategic Objectives and Expected Milestones
Report top-line data from UPLIFT registrational trial in mid-2023, submit potential BLA around year end…
Reklaim Provides CCPA Complaint Data & Do Not Sell Signals To Privacy-Focused Clientele via Snowflake Marketplace
Customers will be able to leverage Snowflake’s single, integrated platform to ensure a safe environment…
Overwhelming interest among global financial leaders to attend 16th Asian Financial Forum
HONG KONG, Jan 6, 2023 – (ACN Newswire) – The 16th Asian Financial Forum (AFF),…
Greenlight Reinvents Financial Education with Level Up — a Gamified Financial Literacy Curriculum for Kids and Teens
Family fintech pioneers new interactive financial literacy game to boost money confidence, knowledge, and skills…
Domo Executives to Participate in the 25th Annual Needham Growth Conference
SILICON SLOPES, Utah–(BUSINESS WIRE)–Domo (Nasdaq: DOMO) today announced management will present at the 25th Annual…
Comcast Promotes Jason S. Armstrong to Chief Financial Officer
PHILADELPHIA–(BUSINESS WIRE)–Comcast Corporation today announced Jason S. Armstrong has been promoted to Chief Financial Officer….